Novo Nordisk Sues Pharmacies, Weight Loss Clinics for Illegally Selling Semaglutide

By PacConAdmin | July 7, 2023

Novo Nordisk has sought legal action against 10 medical spas, weight loss and wellness clinics, and compounding pharmacies in four states for illegally selling non-FDA-approved compounded and counterfeit semaglutide products.
Source: Drug Industry Daily

Posted in Drug Industry Daily